Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

O -GlcNAcylation ameliorates the pathological manifestations of Alzheimer’s disease by inhibiting necroptosis

13 Jan 2021

Abstract excerpt

Increased O -GlcNAcylation can confer neuroprotective effects against necroptosis in the context of Alzheimer’s disease.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Glycosylation and Glycoproteins Research
Share to Neuroinflammation and Neurodegeneration Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33523877
DOI: 10.1126/sciadv.abd3207

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

O -GlcNAcylation ameliorates the pathological manifestations of Alzheimer’s disease by inhibiting necroptosisPMID 33523877Read ↗

O-GlcNAc cycling modulates neurodegeneration.Semantic proximity Read ↗

<i>O</i> -GlcNAcylation effect on Tau in modulating its seeding and cellular transmission in Alzheimer’s DiseaseSemantic proximity Read ↗

Implications of Glycosylation in Alzheimer’s DiseaseSemantic proximity Read ↗

Battling Alzheimer’s Disease: Targeting SUMOylation-Mediated PathwaysSemantic proximity Read ↗

Curcumin Shows Neuroprotection against Oxidative Damage and Alters APP Processing Involving GSK-3β-mediated Protein O-GlcNAcylationSemantic proximity Read ↗

Multilayered N-glycoproteomics reveals impaired N-glycosylation promoting Alzheimer’s diseaseSemantic proximity Read ↗

Current Technologies Unraveling the Significance of Post-Translational Modifications (PTMs) as Crucial Players in NeurodegenerationSemantic proximity Read ↗

Acute increase of protein O-GlcNAcylation in mice leads to transcriptome changes in the brain opposite to what is observed in Alzheimer’s DiseaseSemantic proximity Read ↗

Amyloid ß<sub>1–42</sub> Peptide Induces Galectin-1<sup>S8</sup> O-GlcNAcylation to Lead Microglia MigrationSemantic proximity Read ↗

Dessert or Poison? The Roles of Glycosylation in Alzheimer's, Parkinson's, Huntington's Disease, and Amyotrophic Lateral SclerosisSemantic proximity Read ↗

Brain O-GlcNAcylation: From Molecular Mechanisms to Clinical Phenotype.Semantic proximity Read ↗

Protective effect of increased O-GlcNAc cycling against 6-OHDA induced Parkinson's disease pathologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.